Breakthrough in Malaria Detection: Researchers Develop Dual-Mode Biosensor
Researchers at Saveetha Engineering College have made a significant breakthrough in malaria detection by developing a metasurface biosensor that can simultaneously detect cancer and malaria biomarkers. This innovative device operates at frequencies between 0.189-0.423 THz and demonstrates exceptional sensitivity for both cancer and malaria detection. The sensor's robust performance characteristics and machine learning optimization using Random Forest Regression have achieved R2 scores of up to 94% for refractive index predictions and 89% for incident angle variations, validating its reliability and predictive accuracy.
Key Takeaways:
- The metasurface biosensor can detect cancer and malaria biomarkers simultaneously, offering a unified platform for point-of-care diagnostics.
- The sensor operates at frequencies between 0.189-0.423 THz and demonstrates exceptional sensitivity for both cancer (1000 GHzRIU-1) and malaria (143 GHzRIU-1) detection.
- The device exhibits robust performance characteristics, including consistent quality factors (6.750-10.846), low detection limits (0.065-0.520 RIU), and excellent signal stability across varying experimental conditions.
- Machine learning optimization using Random Forest Regression achieved R2 scores of up to 94% for refractive index predictions and 89% for incident angle variations, validating the sensor's reliability and predictive accuracy.
- The biosensor represents a significant advancement in point-of-care diagnostics, offering potential for widespread implementation in resource-constrained healthcare environments.
- The research has been peer-reviewed and published in the journal Plasmonics.
Statistics:
- The sensor demonstrates exceptional sensitivity of 1000 GHzRIU-1 for cancer detection and 143 GHzRIU-1 for malaria detection.
- The device exhibits consistent quality factors (6.750-10.846) and low detection limits (0.065-0.520 RIU).
- Machine learning optimization achieved R2 scores of up to 94% for refractive index predictions and 89% for incident angle variations.
- The sensor operates at frequencies between 0.189-0.423 THz.
Sources:
- "Vlsi-integrated Cmos-compatible High-performance Terahertz Metasurface Biosensor for Dual-mode Detection of Cancer and Malaria With Machine Learning Optimization." Plasmonics, 2025.
- NewsRx. Research Data from Saveetha Engineering College Update Understanding of Malaria (Vlsi-integrated Cmos-compatible High-performance Terahertz Metasurface Biosensor for Dual-mode Detection of Cancer and Malaria With Machine Learning Optimization). Cancer Weekly. June 17, 2025; p 22.